Skip to content
1st Counsel – Lifestyle
Author:
NRx Pharmaceuticals, Inc.
FDA First Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies Noted for Suicidal Bipolar Depression Treatment from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
August 27, 2026
←
Previous Page
1
2